(Press-News.org) Contact information: Mika Ono
mikaono@scripps.edu
858-784-2052
Scripps Research Institute
Innovative screening strategy swiftly uncovers new drug candidates, new biology
Scripps Research Institute scientists use method to identify compound with promise for obesity-linked diabetes
LA JOLLA, CA—December 22, 2013—Scientists at The Scripps Research Institute (TSRI) have demonstrated a drug-discovery strategy with a double payoff—it enables the rapid selection of chemical compounds that have a desired effect on cells and also highlights how the compounds work.
To illustrate the power of the innovative technique, the TSRI researchers used it to identify a compound that shows promise for treating obesity-linked diabetes. At the same time, they were able to identify the fat-cell enzyme that the compound inhibits—an enzyme that has not yet been a focus of diabetes drug development.
"This integrated strategy we've developed has the potential to accelerate the discovery of important biological pathways and may lead to faster development of new drugs for multiple diseases," said TSRI Associate Professor Enrique Saez.
Saez and his colleague Benjamin F. Cravatt, chair of TSRI's Department of Chemical Physiology, were the senior authors of the new study, which is reported December 22, 2013, in an advance online issue of Nature Chemical Biology.
Facilitating Drug Discovery
The new strategy has great potential to streamline drug discovery, a process whose importance to human health can hardly be overemphasized.
Typically, pharmaceutical scientists start the discovery process by "screening" large libraries of chemical compounds in search of one or a few that might treat disease. The dominant strategy of recent decades has been to screen compounds for a specific activity against a known target, for example, inhibiting the function of a certain enzyme thought to be critical for the disease in question. A key advantage of this "target-based" screening is that it uses biochemical tests that can be done relatively simply in a test-tube—or rather, in a large array of tiny test tubes via automated, rapid screening systems that sort through hundreds of thousands of different compounds.
Target-based screening has enabled scientists to discover many useful new drugs, but some wonder whether this basic discovery strategy has already taken all the "low hanging fruit." In recent years, compounds selected with target-based in vitro tests have seemed to be failing increasingly often when tested in the more realistic biological environments of cells and animals.
An older strategy, "phenotypic" screening, avoids much of this problem by testing compounds for their ability to produce a desired effect directly on living cells. Unfortunately, such cell-based tests often leave open the question of how a useful compound works. "If you don't know what its relevant molecular target is, then developing that compound into a drug—optimizing its potency, its selectivity, its half-life in the bloodstream and so on—is going to be difficult," said Saez.
Identifying the molecular targets of compounds selected by phenotypic screens is typically burdensome and time-consuming. But in their new study, Saez, Cravatt and their colleagues were able to speed up the process dramatically. Indeed, their combined phenotypic screening and target-identification approach enabled them to quickly discover, characterize and carry out preclinical tests of a potential new drug for obesity-linked diabetes: a complex metabolic disorder that affects 347 million people worldwide.
A New Diabetes Drug Candidate, Plus Insights into the Disease
The strategy makes use of the increasing availability of special libraries of related compounds that act as inhibitors of entire enzyme classes. In this case, the researchers used a set of compounds, recently synthesized by Cravatt's laboratory, that tend to inhibit serine hydrolases—a vast enzyme family whose members participate in most biological processes in mammals.
The scientists started with a phenotypic screen, testing their library of compounds for the ability to make young fat cells mature faster and store more fat. Better fat storage means that less fat leaks from fat cells into the liver, muscles and pancreas—a process that frequently occurs with obesity, often interfering with insulin signaling enough to bring on diabetes.
The screen quickly yielded several compounds that had a strong effect in promoting fat-cell fat storage. The researchers then used a method called "activity-based profiling" to identify the fat-cell serine hydrolases that the compounds inhibited most strongly. One of the most potent compounds, WWL113, turned out to work principally by inhibiting Ces3, a serine hydrolase enzyme that scientists have not studied in the context of obesity or diabetes.
The researchers quickly demonstrated WWL113's effectiveness in two different mouse models of obesity-linked diabetes—one in which the mice are genetically programmed to become obese and diabetic, and another in which normal mice are made obese and diabetic with a high-fat diet. "The treated animals showed resistance to weight gain—they were not putting on as much weight as the controls," said Saez. "Their blood biochemistry also was getting normalized; their glucose, triglyceride and cholesterol levels were coming down towards normal levels."
In these mouse tests, WWL113—without any optimization for use as a drug—performed about as well as the FDA-approved diabetes treatment rosiglitazone (Avandia). Notably, the new compound lacked one of the side effects that drugs in rosiglitazone's class have in mice: the toxic accumulation of lipids in the liver.
"Our compound clears lipids from the diabetic mouse liver, whereas rosiglitazone has the opposite effect," said Saez.
To explore the relevance of these results to humans, the TSRI team worked with collaborating researchers in Australia to test fat samples from obese humans and diabetics. The tests confirmed that the human version of Ces3 also is unusually active in such patients. This suggests that an inhibitor may also work as a diabetes treatment in people.
Saez and his colleagues will next focus on using the new screening strategy to uncover more biological pathways that could yield new mechanisms to develop potential therapies.
INFORMATION:
Contributors to the study, "Integrated phenotypic and activity-based profiling links Ces3 to obesity and diabetes," also included first author Eduardo Dominguez, then a postdoctoral fellow in the Saez Laboratory; as well as TSRI's Andrea Galmozzi, Jae Won Chang, Ku-Lung Hsu, Joanna Pawlak, Weiwei Li, Cristina Godio, Jason Thomas, David Partida, Sherry Niessen and Daniel K. Nomura; and Australian researchers Paul E. O'Brien and Matthew J. Watt of Monash University, and Aaron P. Russell of Deakin University.
The study was funded in part by the National Institutes for Health (DK081003, DK099810), the American Diabetes Association, The McDonald's Center for Type 2 Diabetes and Obesity, the National Health and Medical Research Council of Australia, the Hewitt Foundation for Medical Research and the Xunta de Galicia, Spain.
Innovative screening strategy swiftly uncovers new drug candidates, new biology
Scripps Research Institute scientists use method to identify compound with promise for obesity-linked diabetes
2013-12-27
ELSE PRESS RELEASES FROM THIS DATE:
'Be different or die' does not drive evolution
2013-12-27
'Be different or die' does not drive evolution
A new study has found that species living together are not forced to evolve differently to avoid competing with each other, challenging a theory that has held since Darwin's Origin of Species.
By ...
Greenland ice stores liquid water year-round
2013-12-27
Greenland ice stores liquid water year-round
Potential for storing meltwater important for calculating sea-level rise
Dec. 22, 2013 – Researchers at the University of Utah have discovered a new aquifer in the Greenland Ice Sheet that holds liquid water all ...
Researchers create largest evolutionary 'timetree' of land plants to investigate traits that permit survival in cold climates
2013-12-27
Researchers create largest evolutionary 'timetree' of land plants to investigate traits that permit survival in cold climates
A team of researchers studying plants has assembled the largest dated evolutionary tree, using it to show the order in which flowering plants ...
Solar activity not a key cause of climate change, study shows
2013-12-27
Solar activity not a key cause of climate change, study shows
Climate change has not been strongly influenced by variations in heat from the sun, a new scientific study shows
Climate change has not been strongly influenced by variations in heat from the ...
York scientists' significant step forward in biofuels quest
2013-12-27
York scientists' significant step forward in biofuels quest
Scientists at the University of York have made a significant step in the search to develop effective second generation biofuels.
Researchers from the Department of Chemistry at York have discovered ...
Scientists anticipated size and location of 2012 Costa Rica earthquake
2013-12-27
Scientists anticipated size and location of 2012 Costa Rica earthquake
Scientists using GPS to study changes in the Earth's shape accurately forecasted the size and location of the magnitude 7.6 Nicoya earthquake that occurred in 2012 in Costa Rica.
The Nicoya ...
The analogue of a tsunami for telecommunication
2013-12-27
The analogue of a tsunami for telecommunication
Development of electronics and communication requires a hardware base capable for increasingly larger precision, ergonomics and throughput. For communication and GPS-navigation satellites, it is of great importance ...
Study: Some plants may not adapt quickly to future climate change
2013-12-27
Study: Some plants may not adapt quickly to future climate change
GAINESVILLE, Fla. --- Using the largest dated evolutionary tree of flowering plants ever assembled, a new study suggests how plants developed traits to withstand low temperatures, with implications ...
Solitons in a crystal
2013-12-27
Solitons in a crystal
Soliton water waves can travel several kilometers without any significant change in their shape or amplitude, as opposed to normal waves, which widen as they travel, and eventually disappear. Discovered over 150 years ...
Annals of Internal Medicine tip sheet for Dec. 24, 2013
2013-12-27
Annals of Internal Medicine tip sheet for Dec. 24, 2013
Embargoed news from Annals of Internal Medicine
1. Unprecedented but Justified. Princeton meningitis outbreak calls for "compassionate use" of unlicenced vaccine
In the wake of Princeton University's ...
LAST 30 PRESS RELEASES:
Thirty-year mystery of dissonance in the “ringing” of black holes explained
Less intensive works best for agricultural soil
Arctic rivers project receives “national champion” designation from frontiers foundation
Computational biology paves the way for new ALS tests
Study offers new hope for babies born with opioid withdrawal syndrome
UT, Volkswagen Group of America celebrate research partnership
New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll
Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes
University of Cincinnati Cancer Center presents research at AACR 2025
Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025
AACR: Researchers share promising results from MD Anderson clinical trials
New research explains why our waistlines expand in middle age
Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker
Chips off the old block
Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia
Cutting the complexity from digital carpentry
Lung immune cell type “quietly” controls inflammation in COVID-19
Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity
State and sociodemographic trends in US cigarette smoking with future projections
Young adults drive historic decline in smoking
NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research
Chimpanzee stem cells offer new insights into early embryonic development
This injected protein-like polymer helps tissues heal after a heart attack
FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology
In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity
Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects
A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions
AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate
Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative
Structure dictates effectiveness, safety in nanomedicine
[Press-News.org] Innovative screening strategy swiftly uncovers new drug candidates, new biologyScripps Research Institute scientists use method to identify compound with promise for obesity-linked diabetes